Health News Releases

  • Today August 24
October 14, 2020 13:30
Iksuda Therapeutics Enters License Agreement With University of Goettingen to Develop a New Generation of Antibody Drug Conjugates
Iksuda Therapeutics (Iksuda), the developer of enhanced, new-generation of Antibody Drug Conjugates (ADCs), today announces it has executed its option to secure exclusive, worldwide rights to develop
October 13, 2020 10:55
Researchers Use Masimo ORi™, Oxygen Reserve Index, to Predict the Need for Postoperative Oxygen Therapy in Pediatric Patients with Obstructive Sleep Apnea
Masimo (NASDAQ: MASI) today announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA). In this independent
October 12, 2020 21:15
Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced interim results from the VISIBLE open-label extension (OLE) study on the long-term safety and efficacy of maintenan
October 12, 2020 20:30
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
Galderma today announced the presentation of data from clinical trials of its aesthetic solutions and pipeline in five abstracts at the virtual American Society for Dermatologic Surgery (ASDS) 2020 An
October 12, 2020 19:40
Medical Korea Brand Proclamation Ceremony & Symposium
Since 2009, Korea has been promoting its medical competitiveness, and established a national medical brand titled “Smart Care, Medical Korea”, to represent the excellence of Korea’s medical services.
October 12, 2020 19:25
Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality
Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging h
October 12, 2020 15:45
Hong Kong Laureate Forum: Calling Outstanding Young Scientists in Astronomy, Life Science and Medicine, and Mathematical Sciences!
Open application for the inaugural Hong Kong Laureate Forum starts today and will end on 13 December 2020. We welcome undergraduates, postgraduates and PhD graduates who are aged 35 or below and study
October 12, 2020 13:20
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced a collaboration and licensing agreement to develop ARO-AAT, a Pha
Siemens Korea awarded students at the 7th Smart NC contest awards ceremony held at Siemens Technolog
October 08, 2020 10:12
Siemens Korea Holds the 7th Smart NC Contest Award Ceremony
Digital Industries (DI) at Siemens Korea (Siemens Ltd. Seoul, SLS) held the 7th Smart Numerical Control (NC) Contest Award Ceremony on October 7 at Siemens Technology Support Center located in Changwo
October 07, 2020 14:40
Wellcome Sanger Institute Selects Arima Genomics as HiC Technology Partner; Company Announces Early Access Program for high-coverage HiC
Arima Genomics, Inc., a biotechnology company accelerating the adoption of the genome structure information, announced today that its new high-coverage HiC technology has been evaluated and implemente
October 06, 2020 20:30
Marc Benioff and Jim Cramer Supported XPRIZE Next-Gen Mask Challenge Records Massive Participation
XPRIZE today announced that the million dollar Next-Gen Mask Challenge received record-breaking team entry numbers in their newest initiative that called upon young innovators from around the world ag
October 06, 2020 14:34
Good Neighbors Global Impact Foundation, Signing MOU with Watson RnD Sharing and Bion Life Science to Develop the Social Economy
On September 18 (Friday), the Good Neighbors Global Impact Foundation (President Hyun Jin-young) signed a Memorandum of Understanding (MOU) with Watson RnD Sharing (CEO Kim Bong-yoon) and Bion Life Sc
October 05, 2020 18:10
Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards
Synaffix B.V., a biotechnology company enabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces that it has won the “Best ADC Platform Technology” category at the 2020
October 05, 2020 16:45
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
CStone Pharmaceuticals (“CStone”, HKEX: 2616)] and Pfizer Investment Co. Ltd. (“Pfizer Investment”) and Pfizer Corporation Hong Kong Limited (“Pfizer Hong Kong”) (both of which are subsidiaries of Pfi
October 05, 2020 14:40
Savonix and Fujitsu Connected Technologies Limited Partner to Introduce Savonix Mobile App on Raku-Raku Smartphone F-42A
Savonix, a global leader in digital cognitive health testing, and Fujitsu Connected Technologies Limited (FCNT), one of the major smartphone manufacturers in Japan, unveiled Savonix Mobile-a digital c
September 29, 2020 17:46
Boehringer Ingelheim invests to further develop the pet care market in China
Boehringer Ingelheim has acquired an equity stake in China-based New Ruipeng Group (NRP Group). NRP Group is a fast-growing business that offers veterinary care, e-commerce and many other services to
September 29, 2020 11:00
PCI Pharma Services Introduces First-of-its-Kind Digital Platform to Provide Clients with Real-Time Supply Chain Data and Analytics
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider today announced the launch of pci | bridge, an innovative digital platform that will giv
September 25, 2020 17:43
Vifor Pharma announces outcome of AFFIRM-AHF topline data
Regulatory News: Vifor Pharma today announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject® (intravenous ferric carboxymaltose) on heart failure hospitalizations and ca
September 25, 2020 14:10
Careismatic Brands Launches “19 Days of Gratitude” Global Campaign to Support Nurses and the DAISY Foundation
Careismatic Brands, the world’s largest designer and manufacturer of medical apparel, today announced the launch of a global tribute and charitable fundraising campaign, “19 Days of Gratitude,” spotli
September 23, 2020 15:00
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than 2 million treatments worldwide with DUROLANE, its single-injection, hyaluronic acid (
September 21, 2020 11:45
Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the company is presenting data from its lung cancer portfolio at the virtual European Society for Medical Onco
September 18, 2020 17:25
Patient recruitment starts for the international PRO-SID study evaluating Panzyga® for primary prophylaxis in patients with chronic lymphocytic leukaemia and secondary immunodeficiency
Octapharma is pleased to announce that the first site for the international PRO-SID (Primary Infection Prophylaxis with Panzyga® in Secondary Immunodeficiency in Chronic Lymphocytic Leukaemia) study w
September 18, 2020 16:02
Vifor Pharma Group Announces Successful Sale of OM Pharma
Regulatory News: Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include:
September 18, 2020 14:55
Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointmen
September 18, 2020 11:40
BOEHRINGER INGELHEIM AND MIRATI THERAPEUTICS ANNOUNCE CLINICAL COLLABORATION TO STUDY BI 1701963, A SOS1::PAN-KRAS INHIBITOR IN COMBINATION WITH MRTX849, A KRAS G12C SELECTIVE INHIBITOR
Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independe
25 per page50 per page75 per page100 per page